Keyphrases
Allograft Rejection
47%
Kidney
46%
Transplantation
44%
Human Cytomegalovirus
43%
T Cells
40%
Cytomegalovirus
40%
Transplantation Model
32%
Allograft
31%
Mouse Model
27%
Organ Transplantation
26%
Latently Infected
25%
Murine Model
25%
Kidney Transplantation
25%
Small Intestine
25%
Transplantation Tolerance
24%
Immunosuppression
23%
Splenocytes
23%
T Cell Activation
22%
Xenograft
22%
Cytomegalovirus Reactivation
21%
Latency
21%
Liver
21%
Ischemia-reperfusion Injury
20%
Cardiac Allograft
20%
Allogeneic
20%
Acute Allograft Rejection
20%
Kidney Transplant
19%
Monoclonal Antibody
18%
Kidney Transplant Rejection
18%
Immune Response
18%
Allograft Survival
17%
Early Gene Expression
17%
Tumor Necrosis Factor-α
17%
Major Immediate Early Promoter
17%
Heart Allograft
16%
CD4+CD25+ Regulatory T Cells
16%
Intestinal Transplantation
15%
CD45RB
15%
Transplant Rejection
15%
Graft Tolerance
15%
Dendritic Cells
15%
MHC Class II
15%
Extracellular Matrix
14%
Acute Rejection
14%
Spleen
14%
Heterotopic
13%
Alloantigen
13%
TNF Receptor 1 (TNFR1)
13%
NF-B
12%
Bioresorbable
12%
Immunology and Microbiology
Allograft
100%
T Cell
66%
Transplant Rejection
53%
Cytomegalovirus
48%
CD4
37%
Gene Expression
34%
Murine Cytomegalovirus
30%
Regulatory T Cell
30%
Reperfusion
29%
Mouse Model
26%
Splenocyte
26%
Immunity
25%
CD25
24%
Organ Transplantation
22%
Acute Graft Rejection
22%
Tumor Necrosis Factor
22%
Immunology
21%
Immunosuppression
21%
Xenograft
21%
Monoclonal Antibody
19%
Immediate Early Gene
18%
Cytokine
18%
Cardiac Graft Rejection
16%
Macrophage
15%
Immunotherapy
15%
Liver Transplantation
15%
Promoter Region
15%
Dendritic Cell
14%
Kidney Transplantation
14%
Long Term Survival
14%
Tumor Necrosis Factor Receptor
14%
Immune Response
14%
Cytotoxic T-Cell
14%
Signal Transduction
13%
Knockout Mouse
13%
CD8
12%
Alloantigen
12%
Cyclophosphamide
12%
Innate Immune System
12%
Myeloid
12%
Major Histocompatibility Complex
12%
T Cell Activation
11%
Intestine
11%
Wild Type
11%
Immunocompetent Cell
11%
T-Helper Cell
11%
Murine
11%
Human Cytomegalovirus
11%
Toll-Like Receptor
11%
Xenotransplantation
11%
Medicine and Dentistry
Allograft
65%
Transplantation
63%
Graft Rejection
55%
Cytomegalovirus
32%
Immunity
30%
Murine Cytomegalovirus
29%
Kidney Transplantation
28%
Gene Expression
27%
T Cell
26%
Immunosuppressive Treatment
23%
Graft Survival
23%
Infusion
21%
Xenograft
21%
Reperfusion Injury
20%
Regulatory T Cell
19%
Heart Transplantation
18%
Tumor Necrosis Factor
17%
Monoclonal Antibody
16%
Organ Transplantation
16%
Kidney Graft
16%
Extracellular Matrix
15%
Liver Transplantation
15%
Immediate Early Gene
15%
Long Term Survival
14%
Promoter Region
13%
Heterotopic
13%
Kidney Allograft Rejection
12%
In Vitro
12%
Receptor
12%
Ex Vivo
12%
Cyclophosphamide
12%
Macrophage
12%
T Cell Activation
11%
Intestine Transplantation
11%
Xenotransplantation
11%
Diseases
10%
Intestinal Transplantation
10%
Cholestasis
10%
Kidney Graft Rejection
10%
Cardiac Graft Rejection
10%
Enhancer Region
10%
Immunotherapy
10%
Kidney Ischemia
10%
Bile Duct Ligation
10%
Human Cytomegalovirus
10%
Signal Transduction
10%
Heart Graft
9%
Alloantigen
9%
Epithelial Cell
9%
Immune Response
9%